Ignite Creation Date:
2024-05-05 @ 12:06 PM
Last Modification Date:
2024-10-26 @ 9:20 AM
Study NCT ID:
NCT00248482
Status:
COMPLETED
Last Update Posted:
2013-04-29
First Post:
2005-11-03
Brief Title:
Imatinib Mesylate After Irinotecan and Cisplatin in Treating Patients With Extensive-Stage Small Cell Lung Cancer
Sponsor:
Barbara Ann Karmanos Cancer Institute
Organization:
Barbara Ann Karmanos Cancer Institute
Organization Data
Organization:
Barbara Ann Karmanos Cancer Institute
Class:
OTHER
Study ID:
CDR0000445222
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Barbara Ann Karmanos Cancer Institute
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| National Cancer Institute NCI | NIH |
| Novartis Pharmaceuticals | INDUSTRY |